• Data Cube
  • Home
  • Project
  • Partners
  • Downloads
  • News
  • Background
  • Links
  • Advisory Group
  • Contact
  • Data Cube
  • Home
  • Project
  • Partners
  • Downloads
  • News
  • Background
  • Links
  • Advisory Group
  • Contact
Partners
Academic
 
The Chancellor, Masters and Scholars of the University of Oxford (UOXF)
 
Erasmus Universitair Medisch Centrum Rotterdam (EMC)
 
Universiteit Maastricht (UM)
 
Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAP JORDI GOL)
 
Københavns Universitet (UCPH)
 
University of Edinburgh (UEDIN)
 
Goeteborgs Universitet (UGOT)
 
Aarhus Universitet (AU)
 
Academisch Ziekenhuis Leiden – Leids Universitair Centrum (LUMC)
 
London School of Economics and Political Science (LSE)
 
CHU Bordeaux (Memento)
 
Rijksuniversiteit Groningen (RUG)
EFPIA
 
Novartis Pharma AG (Novartis)
 
Eli Lilly and Company Ltd (Eli Lilly)
 
F. Hoffmann‐La Roche Ltd (ROCHE)
 
Janssen Pharmaceutica NV (JPNV)
 
GE Healthcare Ltd (GE)
 
AC Immune SA (AC Immune)
 
Takeda Development Centre Europe LTD (TAKEDA)
 
Biogen (BIOGEN)
 
H. Lundbeck A/S (HLU)
Regulatory Agencies
 
National Institute for Health and Care Excellence (NICE)
 
Agentschap College ter Beoordeling van Geneesmiddelen (CBG/MEB)
Patient Organisation
 
Alzheimer Europe (AE)
SMEs
 
IXICO Technologies Ltd (IXICO)
 
Synapse Research Management Partners S.L (SYNAPSE)
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 116020 (“ROADMAP”). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Copyright ©2023 ROADMAP
Contact, Legal Notice & Privacy Policy
Efpia Logo EU Flag Innovative Medicines Intiative Logo